High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.

Cancer Manag Res · 2019 · PMC6489580 · PMID 31114346

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

marginally significantP =0.07so close (0.05 < p ≤ 0.1)

High CD3D/CD4 ratio was associated with significantly improved survival in two of three cohorts ( GSE31684 , P =0.02; GSE5287 , P =0.035) and marginally significant survival benefits in the other cohort (CIT, P =0.07).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.